1. Home
  2. BDSX vs PAI Comparison

BDSX vs PAI Comparison

Compare BDSX & PAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$13.29

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset Investment Grade Income Fund Inc.

PAI

Western Asset Investment Grade Income Fund Inc.

HOLD

Current Price

$12.32

Market Cap

116.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
PAI
Founded
2005
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
122.0M
116.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BDSX
PAI
Price
$13.29
$12.32
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
55.4K
10.8K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
4.78%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$88,499,000.00
N/A
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.25
$11.72
52 Week High
$20.21
$13.22

Technical Indicators

Market Signals
Indicator
BDSX
PAI
Relative Strength Index (RSI) 43.74 51.64
Support Level $6.00 $11.72
Resistance Level $16.26 $12.33
Average True Range (ATR) 1.04 0.14
MACD -0.22 0.03
Stochastic Oscillator 26.76 76.33

Price Performance

Historical Comparison
BDSX
PAI

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About PAI Western Asset Investment Grade Income Fund Inc.

Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. Its primary investment objective is to seek a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. To a lesser extent, the fund also invests in privately placed debt securities and in certain equity securities. Capital appreciation is its secondary investment objective. The fund invests a majority of its net assets in fixed income securities that are rated in the Baa or BBB categories or above at the time of purchase by one or more Nationally Recognized Statistical Rating Organizations (NRSROs) or unrated securities of comparable quality at the time of purchase (as determined by the investment adviser).

Share on Social Networks: